Clinical trial

Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis

NCT00815906

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention SBI-087 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-12-01

PhasePHASE1

Conditions

Arthritis, Rheumatoidunresolved

Interventions

SBI-087DRUG

Sponsors & collaborators

Pfizerlead sponsor

Emergent Product Development Seattle LLCcollaborator

Mapped research locations

TokyoJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00815906 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.